TNYA•benzinga•
Tenaya Therapeutics Announced Presentation Of TN-201 Gene Therapy Data For MYBPC3-Associated Hypertrophic Cardiomyopathy At ACC 2025 In Chicago; Includes 1-Year Patient Assessments From MyPEAK-1 Phase 1b/2 Trial
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 19, 2025 by benzinga